Skip to main content
OpenTrials

Clinical trial condition

Eye Diseases, Hereditary

Explore clinical trials studying Eye Diseases, Hereditary. Study availability and eligibility vary by location and protocol.

836 public trials 191 recruiting studies
Refine in advanced search Browse all conditions

Eye Diseases, Hereditary trial results

Completed

A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease

NCT05331300

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +19 more
Locations
  • Site AU05 Hurstville, New South Wales, Australia
  • Site AU03 Brisbane, Queensland, Australia
  • Site AU01 Melbourne, Victoria, Australia
  • Site HK01 Shatin, Hong Kong
View Trial Details
Completed

Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease

NCT02023866

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +40 more
Locations
  • University of California at San Diego (UCSD) San Diego, California, United States
  • Stanford University Stanford, California, United States
  • Akron Children's Hospital Akron, Ohio, United States
  • Baylor College of Medicine Houston, Texas, United States
View Trial Details
Completed

Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease

NCT01868997

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations
  • Jules Stein Eye Institute at UCLA Los Angeles, California, United States
  • University of Denver Aurora, Colorado, United States
  • Emory University Department of Ophthalmology Atlanta, Georgia, United States
  • University of Iowa Hospitals and Clinics, Department of Ophthalmology Iowa City, Iowa, United States
View all 15 locations
View Trial Details
Completed

Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity

NCT04966741

Conditions
Abnormalities, Multiple, Bardet-Biedl Syndrome, Body Weight, +23 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Columbia University Medical Center, Division of Pediatric Endocrinology, Diabetes and Metabolism New York, United States
  • Marshfield Clinic Research Foundation Marshfield, Wisconsin, United States
  • Sydney Children's Hospital Randwick, Australia
View Trial Details
Completed

Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway

NCT05194124

Conditions
Abnormalities, Multiple, Bardet-Biedl Syndrome, Brain Diseases, +16 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Marshfield Clinic Research Institute Marshfield, Wisconsin, United States
  • Alberta Health Services Edmonton, Alberta, Canada
  • Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum Berlin, Germany
View Trial Details

Related conditions